{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:17:46Z","timestamp":1779110266050,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z01-ES-100485"],"award-info":[{"award-number":["Z01-ES-100485"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z01-ES-025034"],"award-info":[{"award-number":["Z01-ES-025034"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bcp.2026.117803","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:19:46Z","timestamp":1770855586000},"page":"117803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["GLIS3, a novel regulator of eicosanoid gene expression and metabolism in normal kidney and polycystic kidney disease"],"prefix":"10.1016","volume":"247","author":[{"given":"Chitrangda","family":"Srivastava","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Soon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Edin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanushree","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred B.","family":"Lih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin B.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl C.","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-4445","authenticated-orcid":false,"given":"Anton M.","family":"Jetten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2026.117803_b0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.beem.2017.04.007","article-title":"The role of GLIS3 in thyroid disease as part of a multisystem disorder","volume":"31","author":"Dimitri","year":"2017","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"19","key":"10.1016\/j.bcp.2026.117803_b0010","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1007\/s00018-018-2841-9","article-title":"GLIS1-3 transcription factors: critical roles in the regulation of multiple physiological processes and diseases","volume":"75","author":"Jetten","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.117803_b0015","doi-asserted-by":"crossref","DOI":"10.1002\/stem.2449","article-title":"Transcription factor GLIS3: a New and critical Regulator of Postnatal Stages of Mouse Spermatogenesis","author":"Kang","year":"2016","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_b0020","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1172\/JCI94417","article-title":"GLIS3 is indispensable for TSH\/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation","volume":"127","author":"Kang","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bcp.2026.117803_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157138","article-title":"The Spatiotemporal Pattern of Glis3 Expression Indicates a Regulatory Function in Bipotent and Endocrine Progenitors during Early Pancreatic Development and in Beta, PP and Ductal Cells","volume":"11","author":"Kang","year":"2016","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.bcp.2026.117803_b0030","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1093\/nar\/gkg776","article-title":"GLIS3, a novel member of the GLIS subfamily of Kruppel-like zinc finger proteins with repressor and activation functions","volume":"31","author":"Kim","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2026.117803_b0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.21037\/sci.2017.09.01","article-title":"GLIS1-3: emerging roles in reprogramming, stem and progenitor cell differentiation and maintenance","volume":"4","author":"Scoville","year":"2017","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.bcp.2026.117803_b0040","article-title":"Transcription factor GLIS3: critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes","volume":"107632","author":"Scoville","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.117803_b0045","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/nar\/gkn009","article-title":"Functional analysis of the zinc finger and activation domains of Glis3 and mutant Glis3(NDH1)","volume":"36","author":"Beak","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.117803_b0050","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ng1802","article-title":"Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism","volume":"38","author":"Senee","year":"2006","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.bcp.2026.117803_b0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.a.20267","article-title":"Neonatal diabetes mellitus, congenital hypothyroidism, hepatic fibrosis, polycystic kidneys, and congenital glaucoma: a new autosomal recessive syndrome?","volume":"122A","author":"Taha","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"issue":"10","key":"10.1016\/j.bcp.2026.117803_b0060","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1128\/MCB.01620-08","article-title":"Glis3 is associated with primary cilia and Wwtr1\/TAZ and implicated in polycystic kidney disease","volume":"29","author":"Kang","year":"2009","journal-title":"Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_b0065","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.febslet.2009.05.039","article-title":"A murine model of neonatal diabetes mellitus in Glis3-deficient mice","volume":"583","author":"Watanabe","year":"2009","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bcp.2026.117803_b0070","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/nbm.3281","article-title":"4D MRI of polycystic kidneys from rapamycin-treated Glis3-deficient mice","volume":"28","author":"Xie","year":"2015","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-017-0160-z","article-title":"Extended clinical features associated with novel Glis3 mutation: a case report","volume":"17","author":"Alghamdi","year":"2017","journal-title":"BMC Endocr. Disord."},{"issue":"9","key":"10.1016\/j.bcp.2026.117803_b0080","article-title":"A Neonate with Diabetes Mellitus, Congenital Hypothyroidism, and Congenital Glaucoma","volume":"14","author":"Boddu","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.bcp.2026.117803_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.673755","article-title":"Case Report: Neonatal Diabetes Mellitus Caused by a Novel GLIS3 Mutation in Twins","volume":"12","author":"London","year":"2021","journal-title":"Front. Endocrinol. (lausanne)."},{"key":"10.1016\/j.bcp.2026.117803_b0090","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/pedi.13341","article-title":"Case report: Neonatal diabetes mellitus with congenital hypothyroidism as a result of biallelic heterozygous mutations in GLIS3 gene","volume":"23","author":"Perdas","year":"2022","journal-title":"Pediatr. Diabetes."},{"issue":"4","key":"10.1016\/j.bcp.2026.117803_b0095","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4274\/jcrpe.galenos.2022.2021-12-19","article-title":"Neonatal Diabetes, Congenital Hypothyroidism, and Congenital Glaucoma Coexistence: a Case of GLIS3 Mutation","volume":"15","author":"Sarikaya","year":"2023","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.bcp.2026.117803_b0100","article-title":"Ciliopathies and the Kidney: a Review","author":"McConnachie","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.117803_b0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41581-018-0108-1","article-title":"Progress in the understanding of polycystic kidney disease","volume":"15","author":"Torres","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117803_b0110","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1152\/physrev.00018.2024","article-title":"Physiologic mechanisms underlying polycystic kidney disease","volume":"105","author":"Boletta","year":"2025","journal-title":"Physiol. Rev."},{"issue":"19","key":"10.1016\/j.bcp.2026.117803_b0115","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2025.0310","article-title":"Autosomal Dominant Polycystic Kidney Disease: a Review","volume":"333","author":"Chebib","year":"2025","journal-title":"J. Am. Med. Assoc."},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126523","article-title":"Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease","volume":"22","author":"Cordido","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.117803_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166348","article-title":"The genetics of Autosomal Recessive Polycystic Kidney Disease (ARPKD)","volume":"1868","author":"Goggolidou","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_b0135","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41581-019-0183-y","article-title":"The pathobiology of polycystic kidney disease from a metabolic viewpoint","volume":"15","author":"Menezes","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bcp.2026.117803_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2020","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121584","article-title":"The Interplay between Immune and Metabolic Pathways in Kidney Disease","volume":"12","author":"Qu","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.117803_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102052","article-title":"GLIS3: a novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease","volume":"90","author":"Collier","year":"2024","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.bcp.2026.117803_b0155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1083\/jcb.201006173","article-title":"The cell biology of polycystic kidney disease","volume":"191","author":"Chapin","year":"2010","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2215\/CJN.04140510","article-title":"Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease","volume":"6","author":"Menon","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117803_b0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/nep.12045","article-title":"Role of interstitial inflammation in the pathogenesis of polycystic kidney disease","volume":"18","author":"Ta","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.bcp.2026.117803_b0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-981-13-8871-2_5","article-title":"Polycystic Kidney Disease and Renal Fibrosis","volume":"1165","author":"Xue","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcp.2026.117803_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109646","article-title":"Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease","volume":"72","author":"Zhang","year":"2020","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.bcp.2026.117803_b0180","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1681\/ASN.2011010084","article-title":"Macrophages promote cyst growth in polycystic kidney disease","volume":"22","author":"Karihaloo","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2026.117803_b0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-981-10-2041-4_4","article-title":"Inflammation and Fibrosis in ADPKD","volume":"933","author":"Mun","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2026.117803_b0190","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","article-title":"A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.117803_b0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","article-title":"Inflammation and Fibrosis in Polycystic Kidney Disease","volume":"60","author":"Song","year":"2017","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.bcp.2026.117803_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102220","article-title":"Prostaglandins as potential targets for the treatment of polycystic kidney disease","volume":"164","author":"Aukema","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"5","key":"10.1016\/j.bcp.2026.117803_b0205","doi-asserted-by":"crossref","first-page":"F1622","DOI":"10.1152\/ajprenal.00036.2007","article-title":"EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells","volume":"293","author":"Elberg","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117803_b0210","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1681\/ASN.2017030252","article-title":"Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology","volume":"28","author":"Fan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117803_b0215","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2215\/CJN.0000000000000269","article-title":"Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease","volume":"18","author":"Geurts","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117803_b0220","doi-asserted-by":"crossref","first-page":"F1425","DOI":"10.1152\/ajprenal.00010.2012","article-title":"Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia","volume":"303","author":"Liu","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117803_b0225","doi-asserted-by":"crossref","first-page":"F575","DOI":"10.1152\/ajprenal.90705.2008","article-title":"Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD","volume":"296","author":"Park","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2026.117803_b0230","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1681\/ASN.2007070771","article-title":"20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease","volume":"19","author":"Park","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.bcp.2026.117803_b0235","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1074\/jbc.M112.407981","article-title":"Epoxyeicosatrienoic acids (EETs) regulate epithelial sodium channel activity by extracellular signal-regulated kinase 1\/2 (ERK1\/2)-mediated phosphorylation","volume":"288","author":"Pidkovka","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.117803_b0240","doi-asserted-by":"crossref","first-page":"F556","DOI":"10.1152\/ajprenal.90613.2008","article-title":"Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy","volume":"296","author":"Luo","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117803_b0245","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1681\/ASN.2012020126","article-title":"PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis","volume":"23","author":"Ito","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bcp.2026.117803_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109568","article-title":"Role of transcription factor hepatocyte nuclear factor-1beta in polycystic kidney disease","volume":"71","author":"Shao","year":"2020","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2026.117803_b0255","doi-asserted-by":"crossref","first-page":"F821","DOI":"10.1152\/ajprenal.00257.2006","article-title":"Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease","volume":"293","author":"Sankaran","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0260","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7150\/ijms.27719","article-title":"Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease","volume":"16","author":"Zhang","year":"2019","journal-title":"Int. J. Med. Sci."},{"issue":"15","key":"10.1016\/j.bcp.2026.117803_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153683","article-title":"Arachidonic Acid Metabolism and Kidney Inflammation","volume":"20","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.117803_b0270","doi-asserted-by":"crossref","first-page":"F138","DOI":"10.1152\/ajprenal.00052.2022","article-title":"Epoxyeicosatrienoic acid administration or soluble epoxide hydrolase inhibition attenuates renal fibrogenesis in obstructive nephropathy","volume":"324","author":"Noh","year":"2023","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"19","key":"10.1016\/j.bcp.2026.117803_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910714","article-title":"Epoxyeicosatrienoic Acids and Fibrosis: recent Insights for the Novel Therapeutic strategies","volume":"22","author":"Guan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.117803_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062793","article-title":"Kidney-Targeted Epoxyeicosatrienoic Acid Analog, EET-F01, Reduces Inflammation, Oxidative stress, and Cisplatin-Induced Nephrotoxicity","volume":"22","author":"Imig","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117803_b0285","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-19-0182","article-title":"GLIS3 binds pancreatic beta cell regulatory regions alongside other islet transcription factors","author":"Scoville","year":"2019","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00018-024-05113-6","article-title":"GLIS3 expression in the thyroid gland in relation to TSH signaling and regulation of gene expression","volume":"81","author":"Kang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123471","article-title":"GLIS3: a critical Transcription factor in Islet beta-Cell Generation","volume":"10","author":"Scoville","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bcp.2026.117803_b0300","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/gene.20008","article-title":"Tissue-specific expression of cre recombinase from the Pax8 locus","volume":"38","author":"Bouchard","year":"2004","journal-title":"Genesis"},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0305","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13578-023-00979-8","article-title":"GLIS3 regulates transcription of thyroid hormone biosynthetic genes in coordination with other thyroid transcription factors","volume":"13","author":"Kang","year":"2023","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_bib381","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinform."},{"issue":"7","key":"10.1016\/j.bcp.2026.117803_bib382","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinform."},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_bib383","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117803_bib384","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","article-title":"Ultrafast and memory-efficient alignment of short DNA sequences to the human genome","volume":"10","author":"Langmead","year":"2009","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117803_bib385","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.bcp.2026.117803_b0310","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1074\/jbc.RA117.000298","article-title":"Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia","volume":"293","author":"Edin","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_b0315","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2026.117803_b0320","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"10","key":"10.1016\/j.bcp.2026.117803_b0325","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1681\/ASN.2016101095","article-title":"Hepatocyte Nuclear Factor-1beta Regulates Urinary Concentration and Response to Hypertonicity","volume":"28","author":"Aboudehen","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.bcp.2026.117803_b0330","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.51","article-title":"Regulation of prostaglandin EP1 and EP4 receptor signaling by carrier-mediated ligand reuptake","volume":"2","author":"Chi","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1208\/s12248-017-0163-8","article-title":"Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1\/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins","volume":"20","author":"Nakanishi","year":"2017","journal-title":"AAPS J."},{"issue":"6","key":"10.1016\/j.bcp.2026.117803_b0340","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.juro.2012.12.002","article-title":"Comprehensive gene expression changes associated with mouse postnatal kidney development","volume":"189","author":"Wu","year":"2013","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0345","doi-asserted-by":"crossref","first-page":"4","DOI":"10.23876\/j.krcp.21.222","article-title":"Prostaglandin E2 receptors as therapeutic targets in renal fibrosis","volume":"41","author":"Mutsaers","year":"2022","journal-title":"Kidney Res Clin Pract."},{"issue":"12","key":"10.1016\/j.bcp.2026.117803_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122539","article-title":"Prostaglandin E2 in the Regulation of Water Transport in Renal Collecting Ducts","volume":"18","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0355","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MNH.0000000000000750","article-title":"Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis","volume":"31","author":"Chiang","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"2","key":"10.1016\/j.bcp.2026.117803_b0360","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201936R","article-title":"The leukotriene B(4) \/BLT1-dependent neutrophil accumulation exacerbates immune complex-mediated glomerulonephritis","volume":"37","author":"Shioda","year":"2023","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.bcp.2026.117803_b0365","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1046\/j.1523-1755.2003.00215.x","article-title":"Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease","volume":"64","author":"Ogborn","year":"2003","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bcp.2026.117803_b0370","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1096\/fj.02-0460fje","article-title":"Alterations in renal cytosolic phospholipase A2 and cyclooxygenases in polycystic kidney disease","volume":"17","author":"Aukema","year":"2003","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bcp.2026.117803_b0375","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.kint.2020.02.012","article-title":"The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo","volume":"98","author":"Lannoy","year":"2020","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.bcp.2026.117803_b0380","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.kint.2017.01.009","article-title":"The leukotriene B(4)-leukotriene B(4) receptor axis promotes cisplatin-induced acute kidney injury by modulating neutrophil recruitment","volume":"92","author":"Deng","year":"2017","journal-title":"Kidney Int."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:01:46Z","timestamp":1779109306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":81,"alternative-id":["S0006295226001346"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117803","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLIS3, a novel regulator of eicosanoid gene expression and metabolism in normal kidney and polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117803"}}